NDC 73116-101

FARYDAK

Panobinostat

FARYDAK is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Secura Bio, Inc.. The primary component is Panobinostat Lactate.

Product ID73116-101_8368e056-cfe2-4f4b-8033-dd7e14689eaf
NDC73116-101
Product TypeHuman Prescription Drug
Proprietary NameFARYDAK
Generic NamePanobinostat
Dosage FormCapsule
Route of AdministrationORAL
Marketing Start Date2015-02-23
Marketing CategoryNDA / NDA
Application NumberNDA205353
Labeler NameSecura Bio, Inc.
Substance NamePANOBINOSTAT LACTATE
Active Ingredient Strength15 mg/1
Pharm ClassesHistone Deacetylase Inhibitor [EPC],Histone Deacetylase Inhibitors [MoA],Cytochrome P450 2D6 Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 73116-101-06

1 BLISTER PACK in 1 CARTON (73116-101-06) > 6 CAPSULE in 1 BLISTER PACK
Marketing Start Date2015-02-23
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 73116-101-06 [73116010106]

FARYDAK CAPSULE
Marketing CategoryNDA
Application NumberNDA205353
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2015-02-23

Drug Details

Active Ingredients

IngredientStrength
PANOBINOSTAT LACTATE15 mg/1

Pharmacological Class

  • Histone Deacetylase Inhibitor [EPC]
  • Histone Deacetylase Inhibitors [MoA]
  • Cytochrome P450 2D6 Inhibitors [MoA]

NDC Crossover Matching brand name "FARYDAK" or generic name "Panobinostat"

NDCBrand NameGeneric Name
0078-0650FARYDAKpanobinostat
0078-0651FARYDAKpanobinostat
0078-0652FARYDAKpanobinostat
73116-100FARYDAKpanobinostat
73116-101FARYDAKpanobinostat
73116-102FARYDAKpanobinostat

Trademark Results [FARYDAK]

Mark Image

Registration | Serial
Company
Trademark
Application Date
FARYDAK
FARYDAK
86140638 4765286 Live/Registered
SECURA BIO, INC.
2013-12-11
FARYDAK
FARYDAK
79050673 3502071 Live/Registered
Secura Bio, Inc.
2008-02-01

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.